Global Dermal Filler Market Is Expected to Reach $14.4 Billion by 2031: Says AMR

Rise in prevalence of early skin aging, surge in demand for minimal invasive surgical procedure, increase in demand for dermal fillers procedures, rise in the geriatric population, and the increase in self-awareness among young population regarding physical appearance drive the growth of the dermal filler market. Based on region, Asia-Pacific is expected to grow at the fastest rate through 2031.


Portland, OR, Oct. 25, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Dermal Filler Market  generated $5.1 billion in 2021 and is estimated to hit $14.4 billion by 2031, registering a CAGR of 10.8% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario. The report is a helpful source of information for leading market players, new entrants, investors, and stakeholders in devising strategies for the future and taking steps to strengthen their position in the market.

Download Free Sample Report (250 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/7654

Report coverage & details:

Report CoverageDetails
Forecast Period2022­–2031
Market Size in 2031$14.4 billion
CAGR10.8%
No. of Pages in Report250
DriversRise in prevalence of early skin aging
Surge in demand for minimal invasive surgical procedure
Increase in demand for dermal fillers procedures
Rise in geriatric population
Increase in self-awareness among young population regarding physical appearance
OpportunitiesTechnological advancement in medical aesthetic products

Surge in healthcare expenditure
RestraintsHigh costs associated with dermal filler procedures such as fat face and polymethyl-methacrylate microspheres

Covid-19 scenario-

  • The COVID-19 outbreak had a negative impact on the growth of the global dermal filler market.
  • A number of clinics and hospitals were restructured to increase hospital capacities for patients diagnosed with COVID-19. Non-essential surgical procedures were cancelled due to the pandemic. Dermal filler procedures are non-emergency procedures that were given less priority during the pandemic, which significantly hampered the revenue of aesthetic companies and the growth of the market.
  • However, the market is gaining traction in the post-pandemic period and is expected to grow at the same pace in future.

The report offers a detailed segmentation of the global dermal filler market based on type, gender, service provider, and region. The report provides an analysis of each segment and sub-segment with the help of tables and figures. This analysis helps market players, investors, and new entrants in determining the sub-segments to be tapped on to achieve growth in the coming years.

Based on type, the hyaluronic acid (HA) segment accounted for more than two-thirds of the overall dermal filler market in 2021, and is likely to lead the trail by the end of 2031. Moreover, the same segment would cite the fastest CAGR of 11.1% throughout the forecast period. The report also discusses the calcium hydroxylapatite (CaHA), poly l lactic acid, and others segments.

Purchase Inquiry:
https://www.alliedmarketresearch.com/purchase-enquiry/7654

Based on gender, the female segment contributed over 90% of the global dermal filler market in 2021, and is expected to maintain its dominance through 2031. Moreover, the same segment would grow at the fastest CAGR of 10.8% from 2022 to 2031. The report also offers an analysis of the male segment.

Based on service provider, the hospitals segment contributed to more than two-fifths of the global dermal filler market in 2021, and is expected to maintain its dominance through 2031. Moreover, the same segment would grow at the fastest CAGR of 11.1% from 2022 to 2031.

Based on region, the market across North America contributed to nearly two-fifths of the overall dermal filler market in 2021, and is expected to maintain its dominance during the forecast period. However, the Asia-Pacific market would grow at the fastest CAGR of 11.8% from 2022 to 2031. The other provinces discussed in the report include Europe and LAMEA.

The key market players analyzed in the global dermal filler market report include AbbVie Laboratories, Bioxis Pharmaceutical, Cutera Inc., Elan Aesthetics Inc., Galderma SA, MerzPharma GmbH and Co. KGaA, Revance Therapeutics, Sinclair Pharma, Teoxane Laboratories, and Vital Esthetique Laboratories.

The report provides a detailed analysis of these key players of the global dermal filler market. These players have adopted various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, product portfolio, and developments by every market player.


Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Remote Patient Monitoring Market by Condition (Congestive Heart Failure (CHF), Diabetes, Chronic Obstructive Pulmonary Disease (COPD), Blood Pressure, Mental Health, Others), by Component (Devices, Software): Global Opportunity Analysis and Industry Forecast, 2021-2031

Intraoral Scanners Market By Brand (Cadent iTero, 3M ESPE Lava COS, CEREC, E4D, TRIOS, CS, Others), By End User (Hospitals, Dental Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

Mental Health Market by Disorder (Schizophrenia, Alcohol Use Disorders, Bipolar Disorder, Depression, Anxiety, Post-Traumatic Stress Disorder, Substance Abuse Disorders, Eating Disorders, and Other Disorders), Service (Emergency Mental Health Services, Outpatient Counselling, Home-Based Treatment Services, Inpatient Hospital Treatment Services, and Other Services), and Age Group (Pediatric, Adult, and Geriatric): Global Opportunity Analysis and Industry Forecast, 2021-2030

Dental Implants and Prosthetics Market by Products (Dental Implants, Dental Prosthetics), by Materials (Metals, Polymers, Ceramics, Biomaterial): Global Opportunity Analysis and Industry Forecast, 2020-2030

Clinical Trial Management Market by Type (Enterprise-Based and Site-Based), Delivery Mode (Web-Based, On-Premise, and Cloud-Based), Component (Software and Services), and End User (Pharmaceutical & Biopharmaceutical Companies, Clinical Research Organizations, and Healthcare Providers): Global Opportunity Analysis and Industry Forecast, 2021-2030


About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Follow Us on Blog: https://www.globalhealthcareindustry.com/

 

Contact Data